A

Amgen

Makes biotech medicines for serious illnesses

Director – Bioprocess / Process Development - Pivotal Drug Substance

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • A doctorate degree and 4 years of scientific process development experience, or a master's degree and 8 years of scientific process development experience, or a bachelor's degree and 10 years of scientific process development experience.
  • At least 4 years of experience directly managing people and/or leading teams, projects, programs, or directing resource allocation; managerial experience may run concurrently with the required technical experience.
  • Preferred: PhD in Biochemistry, Biochemical Engineering, Chemical Engineering, or a related discipline.
  • Preferred: 10+ years of experience in biopharmaceutical process development.
  • Preferred: Minimum of 4 years of experience directly managing people.
  • Preferred: Deep expertise in either cell culture bioreactor processes or downstream purification processes.
  • Preferred: Strong understanding of late-stage biologics development, including process design, characterization, validation (PPQ), and regulatory interactions.
  • Preferred: Proven ability to provide scientific and engineering leadership on complex cross-functional programs.
  • Preferred: Demonstrated experience in statistical data analysis, technical decision-making, and senior-level communication.
  • Preferred: Track record of developing talent through coaching, mentoring, and feedback.
  • Preferred: Active engagement in the scientific community through publications, patents, and industry forums.

Responsibilities

  • Lead a high-impact, multifunctional drug substance organization integrating cell culture and purification disciplines across multiple sites.
  • Recruit, develop, and retain a strong and diverse team; manage portfolio prioritization and organizational resourcing.
  • Advance integrated drug substance processes through commercial process development, process characterization, lifecycle management, and control strategy development.
  • Partner with engineering, manufacturing, and external network collaborators to enable successful process transfer and commercialization.
  • Author and review global regulatory filings (IND/INDa/MA) and respond to regulatory agency questions.
  • Drive ideation, development, and deployment of innovative and differentiating bioprocess technologies.
  • Contribute to scientific and regulatory eminence through publications, patents, and participation in external conferences and forums.
  • Serve as a member of the Drug Substance Technology extended leadership team and contribute to business, organizational, and change-management strategies.

Desired Qualifications

  • Preferred: PhD in Biochemistry, Biochemical Engineering, Chemical Engineering, or a related discipline.
  • Preferred: 10+ years of experience in biopharmaceutical process development.
  • Preferred: Minimum of 4 years of experience directly managing people.
  • Preferred: Deep expertise in either cell culture bioreactor processes or downstream purification processes.
  • Preferred: Strong understanding of late-stage biologics development, including process design, characterization, validation (PPQ), and regulatory interactions.
  • Preferred: Proven ability to provide scientific and engineering leadership on complex cross-functional programs.
  • Preferred: Demonstrated experience in statistical data analysis, technical decision-making, and senior-level communication.
  • Preferred: Track record of developing talent through coaching, mentoring, and feedback.
  • Preferred: Active engagement in the scientific community through publications, patents, and industry forums.

About the Company

Amgen

Makes biotech medicines for serious illnesses

Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.

Company size
10,001+
Company stage
IPO
Headquarters
Thousand Oaks, CA
Founded
1980

Recently Posted Jobs

Explore more opportunities at Amgen

See more jobs